Miss Anne-Lotte van der Lingen

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

Membership: EHRA Member

Contributor content

Presentation

Depression and anxiety at time of implantable cardioverter defibrillator implantation and the biological link with cardiovascular disease

Presentation

Sex-specific differences in risk stratification of ventricular arrhythmias among implantable cardioverter defibrillator patients: do women differ from men?

Presentation

Incomplete coronary revascularization increases the risk of ventricular arrhythmias in secondary prevention implantable cardioverter defibrillator patients with coronary artery disease

$Prophylactic implantable cardioverter defibrillator implantation in heart failure patients with a reduced ejection fraction: does New York Heart Association class really matter?$

Presentation

Prophylactic implantable cardioverter defibrillator implantation in heart failure patients with a reduced ejection fraction: does New York Heart Association class really matter?

Presentation

Patients in New York Heart Association functional class I might benefit from primary prevention implantable cardioverter defibrillator therapy

Presentation

Postextrasystolic blood pressure potentiation is associated with appropriate device therapy and mortality in implantable cardioverter defibrillator recipients with a reduced LVEF

Explore sponsored resources

Miss Anne-Lotte van der Lingen

Contributor content

Depression and anxiety at time of implantable cardioverter defibrillator implantation and the biological link with cardiovascular disease

Sex-specific differences in risk stratification of ventricular arrhythmias among implantable cardioverter defibrillator patients: do women differ from men?

Incomplete coronary revascularization increases the risk of ventricular arrhythmias in secondary prevention implantable cardioverter defibrillator patients with coronary artery disease

Prophylactic implantable cardioverter defibrillator implantation in heart failure patients with a reduced ejection fraction: does New York Heart Association class really matter?

Patients in New York Heart Association functional class I might benefit from primary prevention implantable cardioverter defibrillator therapy

Postextrasystolic blood pressure potentiation is associated with appropriate device therapy and mortality in implantable cardioverter defibrillator recipients with a reduced LVEF

ESC 365 is supported by